drugset / Trial / NCT01025700

Nabilone & Marijuana Addiction

NCT01025700

Phase 2/3 Completed 35 enrolled University of British Columbia
RandomizedParallel-groupDouble-blindTreatment

Summary

Safety of Nabilone in reducing marijuana craving

Timeline

Start
2009-06
Primary completion
2010-06
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Nabilone Other / unclassified 1 mg

Indications

No indication recorded.